Genetic Inactivation of Peroxiredoxin-I Impairs the Growth of Human Pancreatic Cancer Cells

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with few therapeutic options. The identification of new promising targets is, therefore, an urgent need. Using available transcriptomic datasets, we first found that Peroxiredoxin-1 gene (PRDX1) expression was significantly increased i...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahou, Hajar, Minati, Marie-Albane, Jacquemin, Patrick, Assi, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068151/
https://www.ncbi.nlm.nih.gov/pubmed/33917763
http://dx.doi.org/10.3390/antiox10040570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068151/
https://www.ncbi.nlm.nih.gov/pubmed/33917763
http://dx.doi.org/10.3390/antiox10040570

Ejemplares similares